- Home
- SNDL vs SIGA Comparison
SNDL vs SIGA Comparison
Compare SNDL & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNDL | SIGA |
|---|---|---|
| Founded | 2006 | 1995 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 386.3M | 401.0M |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SNDL | SIGA |
|---|---|---|
| Price | $1.51 | $5.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 961.4K | 475.0K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | ★ 10.97% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | N/A |
| Revenue This Year | $6.09 | N/A |
| Revenue Next Year | $2.59 | $132.36 |
| P/E Ratio | ★ N/A | $17.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.15 | $4.95 |
| 52 Week High | $2.89 | $9.62 |
Technical Indicators
Market Signals| Indicator | SNDL | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 44.57 | 25.09 |
| Support Level | $1.44 | $5.21 |
| Resistance Level | $1.60 | $6.98 |
| Average True Range (ATR) | 0.07 | 0.26 |
| MACD | 0.00 | -0.13 |
| Stochastic Oscillator | 21.05 | 5.31 |
Price Performance
Historical ComparisonAbout SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.